Aurora Innovation enters the back half of August with a sharp divergence at its core: short sellers are adding to already-elevated positions at the same time insiders and early backers are selling into every available rally.
Short interest is the headline story this week — and it has earned its place there. At 12.8% of free float, the short position is meaningfully large, and it jumped roughly 9.6% over the past week alone, from around 186 million shares to just over 204 million. That's the highest level in the 30-day window the data covers, and the move accelerated sharply on August 10-11 when the stock was still trading above $7. The cost to borrow, while still low in absolute terms at 0.70%, has risen 20% in one week and 46% over the past month — a signal that demand for borrows is climbing even if the lending market is not yet stressed. Availability remains comfortable at around 197% of current short interest, meaning plenty of shares are still out there for new shorts to source, so there is no mechanical squeeze pressure building in the lending pool. Taken together, the picture is one of growing conviction on the short side without any of the borrow constraints that could force a cover.
Options traders are not adding much urgency to the bear case. The put/call ratio is running at 0.21, barely a standard deviation above its 20-day average and still well below the 52-week high of 0.40 set earlier this year. That's an unusually call-heavy skew for a stock down nearly 12% on the week — it suggests the options market retains a speculative, upside-oriented character rather than pivoting to downside protection alongside the short sellers.
The Street is split but broadly positive on the longer-term story. Five analysts carry buy-equivalent ratings, while two hold neutrals. Cantor Fitzgerald reiterated Overweight with a $12 target as recently as late July, Needham has maintained Buy with a $13 target, and Craig-Hallum initiated at Buy with an $18 target in June. Goldman Sachs sits at Neutral with a $5 target — the most cautious published figure and one that now sits below the current $6.15 close, highlighting the gap between the bull and bear camps. The bull case rests on Aurora's freight partnerships, a claimed path to gross profit positivity by late 2026, and hardware cost reductions of over 50% on its second-generation kit. The bear case is harder to dismiss near-term: the company recognised just $1 million in revenue last quarter, operating expenses remain in the hundreds of millions annually, and EPS momentum factor scores rank in the bottom decile of the universe. The ORTEX short score is running at 70.3 — elevated and stable for the past week, reflecting a positioning profile that has already priced in significant pessimism without yet tipping into extreme territory.
Insider and backer activity adds another layer of selling pressure worth watching. Index Ventures, which holds a board seat, sold over 3.3 million shares between August 7 and August 13, with the largest single tranche — around 1.4 million shares — going through on August 11. Director Michelangelo Volpi has sold alongside each of those transactions. The 90-day net insider figure is actually positive at $560 million because of earlier activity, but the recent pattern is one-directional: every transaction in the past ten days has been a sale, and the selling was concentrated in the $6.99–$7.05 range, just above where the stock closed Tuesday at $6.15. Uber, the second-largest institutional holder at 12.9% of shares, trimmed its position by 67.5 million shares in the most recent reporting period. Capital Research went the other direction, adding 78 million shares — the biggest institutional buyer in the table — but that was reported through July 31, before this week's drop.
The next earnings print is scheduled for October 28. Last quarter the stock barely moved on the day (+0.5%) but added 7.7% over the following five sessions, suggesting the market has been willing to look past headline losses when the commercial narrative holds. Whether that patience persists after a week in which the stock shed more than 11% — while insiders and early venture backers sold methodically into it — is the question the October print will have to answer.
See the live data behind this article on ORTEX.
Open AUR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
